St. Jude Medical, Inc. (NYSE:STJ) announced pilot study results from the first multi-center study investigating deep brain stimulation (DBS) of Brodmann Area 25 for major depressive disorder. Results of the study, which were presented at the American Psychiatric Association (APA) meeting in Washington, D.C., found that 6 months after the procedure, 56 percent of the patients experienced at least a 40 percent decrease in depressive symptoms.
Popularity: unranked [?]
Related posts:
- Patients In St. Jude Medical Deep Brain Stimulation For Depression Pilot Study Demonstrate Sustained Improvement In Depression Symptoms
- Deep Brain Stimulation For Depression Pilot Study Demonstrates Sustained Improvement In Depression Symptoms
- Deep Brain Stimulation May Offer Hope For Select Patients With Treatment Resistant Major Depression
- New Brain Stimulation Treatment May Offer Hope For Those With Treatment Resistant Depression
- Study Shows Promising Results In Deep Brain Stimulation For Treatment-Resistant Depression
Comments
No Responses to “Results Of Brodmann Area 25 Deep Brain Stimulation Pilot Study Offer Hope For Patients With Severe Depression”